The role of Research & Innovation in the enhancement of older cancer patients care & treatment options, accessibility and Quality of Life during survivorship

Location:Thursday, 9 December 2021, 14.00-15:30 CET

We invite you to join the webinar on Thursday, 9 December 2021 between 14.00-15:30 CET where the topic on cancer research, treatments and quality of live during survivorship will be discussed. The event is hosted my the member of the European Parliament Tomislav Sokol. You can register through


About the event:

Webinar context & objectives: Cancer has become a top health priority for the EU, and it is expected to have an active role in the policy agenda through the EU Beating Cancer Plan. In the meantime, the steady increase in life expectancy, mean age and cancer survivorship across the developed countries together with evidence from cancer and geriatrics care research bring forward the urgent need to deal with the “age issue” as a key component of global cancer care strategies. On the other side, increasing age and comorbidities are often associated with a discriminant lower use of aggressive cancer therapies, as well as a higher neglection for their preferences in health‐related quality of life (HRQOL) care support. At the same time, the novel technologies and AI in digital medicine promise the transformation of health & care services, offering new technical skills to clinicians, that along with their traditional clinical methods can lead to person-centred and effective care & treatment, based on the personalised needs and requirements of patients.


At the event LifeChamps objectives will be presented. These include discussion the innovation of the project and how it can be improved to better serve the needs of older cancer patients and caregivers.


Find more information at: (Flyer) Co-creation of Empowering Smart Cities through Citizen Engagement



This site uses cookies to offer you a better browsing experience. By using the website and agreeing to this policy, you consent to our use of cookies in accordance with the terms of our Privacy Policy.